Return to search

Inhibition of Cysteine Protease by Platinum (II) Diamine Complexes

Chemotherapy is the first line of treatment used in cancer. Chemotherapy drugs such as cisplatin, carboplatin and oxaliplatin are used in treatment. Cisplatin enters the cell through copper transporter CTR1 by passive diffusion and bind to DNA and proteins. Cisplatin is found to inhibit several enzymes targeting cysteine, histidine and methionine residues, which are expected to be responsible for its anticancer activity. A better understanding of how the size and shape and leaving ligands of platinum complexes affect cysteine protease, papain enzyme are studied. This could give new ways to optimize anticancer activity. The activity of papain enzyme was measured on UV-Visible spectroscopy. The inhibition profile of papain with different platinum (II) complexes, and with different combinations was studied.

Identiferoai:union.ndltd.org:WKU/oai:digitalcommons.wku.edu:theses-2139
Date01 December 2011
CreatorsRapolu, Chaitanya
PublisherTopSCHOLAR®
Source SetsWestern Kentucky University Theses
Detected LanguageEnglish
Typetext
Formatapplication/pdf
SourceMasters Theses & Specialist Projects

Page generated in 0.0021 seconds